+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

U.S. In-vitro Fertilization Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 100 Pages
  • October 2026
  • Region: United States
  • Grand View Research
  • ID: 5976487
The U.S. in vitro fertilization market size was valued at USD 5.9 billion in 2025 and is projected to grow from USD 6.2 billion in 2026 to USD 8.0 billion, at a CAGR of 3.7% from 2026 to 2033. The rising prevalence of infertility among couples is driving the growth of the U.S. IVF market. According to the U.S. Centers for Disease Control and Prevention (CDC), in a report published in December 2025, 1.6% of women aged 20-49 years in the U.S. had used in vitro fertilization (IVF) or other assisted reproductive technology (ART) procedures during 2022-2023, highlighting the utilization of assisted reproductive treatments to address fertility challenges.

U.S. In-vitro Fertilization Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global U.S. in-vitro fertilization (IVF) market report based on instruments, procedure type, and end-use:

Instrument Outlook (Revenue, USD Billion, 2021 - 2033)

  • Disposable Devices
  • Culture Media
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
  • Capital Equipment
  • Sperm Analyzer Systems
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Witness Systems
  • Other

Procedure Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Fresh Donor
  • Frozen Donor
  • Fresh Non-Donor
  • Frozen Non-Donor

End-use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Fertility Clinics
  • Hospitals & Others Setting

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. U.S. In Vitro Fertilization Market Variables, Trends & Scope
1.1. Market Lineage Outlook
1.1.1. Parent market outlook
1.2. Market Dynamics
1.2.1. Market driver analysis
1.2.2. Market restraint analysis
1.3. Business Environment Analysis
1.3.1. Industry Analysis - Porter’s Five Forces Analysis
1.3.1.1. Supplier power
1.3.1.2. Buyer power
1.3.1.3. Substitution threat
1.3.1.4. Threat of new entrant
1.3.1.5. Competitive rivalry
1.3.2. PESTLE Analysis
1.4. U.S. In Vitro Fertilization Work Force Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Component Snapshot
2.3. ‘Delivery Mode Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Long Term Care Market Variables, Trends & Scope
3.1. Market segmentation and scope
3.2. Market Lineage Outlook
3.2.1. Parent market outlook
3.2.2. Related/ancillary market outlook.
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.3.3. Market opportunity analysis
3.3.4. Market challenges analysis
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.4.2. PESTLE Analysis
3.5. U.S. In Vitro Fertilization Work Force Analysis
Chapter 4. U.S. In Vitro Fertilization Market Segment Analysis, Instrument, 2021 - 2033 (USD Million)
4.1. U.S. In Vitro Fertilization Market: Instrument Movement Analysis and Market Share, 2025 & 2033
4.2. U.S. In Vitro Fertilization Market Instrument Segment Dashboard, 2021 - 2033
4.2.1. Disposable Devices
4.2.1.1. Disposable devices market, 2021 - 2033 (USD Million)
4.2.2. Culture Media
4.2.2.1. Culture media market, 2021 - 2033 (USD Million)
4.2.2.2. Cryopreservation Media
4.2.2.2.1. Cryopreservation media market, 2021 - 2033 (USD Million)
4.2.2.3. Embryo Culture Media
4.2.2.3.1. Embryo culture media market, 2021 - 2033 (USD Million)
4.2.2.4. Ovum Processing Media
4.2.2.4.1. Ovum processing media market, 2021 - 2033 (USD Million)
4.2.2.5. Sperm Processing Media
4.2.2.5.1. Sperm processing media market, 2021 - 2033 (USD Million)
4.2.3. Equipment
4.2.3.1. Equipment market, 2021 - 2033 (USD Million)
4.2.3.2. Sperm Analyzer
4.2.3.2.1. Sperm analyzer market, 2021 - 2033 (USD Million)
4.2.3.3. Imaging Systems
4.2.3.3.1. Imaging systems market, 2021 - 2033 (USD Million)
4.2.3.4. Ovum Aspiration Pumps
4.2.3.4.1. Ovum aspiration pumps market, 2021 - 2033 (USD Million)
4.2.3.5. Micromanipulator Systems
4.2.3.5.1. Micromanipulator systems market, 2021 - 2033 (USD Million)
4.2.3.6. Incubators
4.2.3.6.1. Incubators market, 2021 - 2033 (USD Million)
4.2.3.7. Gas Analyzers
4.2.3.7.1. Gas analyzers market, 2021 - 2033 (USD Million)
4.2.3.8. Laser Systems
4.2.3.8.1. Laser systems market, 2021 - 2033 (USD Million)
4.2.3.9. Cryosystems
4.2.3.9.1. Cryosystems market, 2021 - 2033 (USD Million)
4.2.3.10. Sperm Separation Devices
4.2.3.10.1. Sperm separation devices market, 2021 - 2033 (USD Million)
4.2.3.11. IVF Cabinets
4.2.3.11.1. IVF cabinets market, 2021 - 2033 (USD Million)
4.2.3.12. Anti-vibration Tables
4.2.3.12.1. Anti-vibration tables market, 2021 - 2033 (USD Million)
4.2.3.13. Witness Systems
4.2.3.13.1. Witness systems market, 2021 - 2033 (USD Million)
4.2.3.14. Other
4.2.3.14.1. Other market, 2021 - 2033 (USD Million)
Chapter 5. U.S. In Vitro Fertilization Market Segment Analysis, Procedure Type, 2021 - 2033 (USD Million)
5.1. U.S. In Vitro Fertilization Market: Procedure Type Movement Analysis and Market Share, 2025 & 2033
5.2. U.S. In Vitro Fertilization Market Procedure Type Segment Dashboard, 2021 - 2033
5.2.1. Fresh Donor
5.2.1.1. Fresh donor market, 2021 - 2033 (USD Million)
5.2.2. Frozen Donor
5.2.2.1. Frozen donor market, 2021 - 2033 (USD Million)
5.2.3. Fresh Non-Donor
5.2.3.1. Fresh non-donor market, 2021 - 2033 (USD Million)
5.2.4. Frozen Non-Donor
5.2.4.1. Frozen non-donor market, 2021 - 2033 (USD Million)
Chapter 6. U.S. In Vitro Fertilization Market Segment Analysis, End-use, 2021 - 2033 (USD Million)
6.1. U.S. In Vitro Fertilization Market: End-use Movement Analysis and Market Share, 2025 & 2033
6.2. U.S. In Vitro Fertilization Market End-use Segment Dashboard, 2021 - 2033
6.2.1. Fertility Clinics
6.2.1.1. Fertility clinics market, 2021 - 2033 (USD Million)
6.2.2. Hospitals & Others Setting
6.2.2.1. Hospitals & others setting market, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, Key Market Participants
7.2. Company Categorization
7.3. Company Profiles
7.3.1. Bayer AG
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product/ Service benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Cook Medical LLC
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product/ Service benchmarking
7.3.2.4. Strategic initiatives
7.3.3. EMD Serono, Inc.
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product/ Service benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Ferring B.V.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product/ Service benchmarking
7.3.4.4. Strategic initiatives
7.3.5. FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product/ Service benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Genea Biomedx
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product/ Service benchmarking
7.3.6.4. Strategic initiatives
7.3.7. EMD Serono, Inc. (Merck KGaA)
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product/ Service benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Merck & Co., Inc.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product/ Service benchmarking
7.3.8.4. Strategic initiatives
7.3.9. The Cooper Companies, Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product/ Service benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Thermo Fisher Scientific, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product/ Service benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Vitrolife
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product/ Service benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Nova IVF
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product/ Service benchmarking
7.3.12.4. Strategic initiatives
7.3.13. RMA Network (Reproductive Medicine Associates)
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product/ Service benchmarking
7.3.13.4. Strategic initiatives
7.3.14. U.S. Fertility
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product/ Service benchmarking
7.3.14.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 List of secondary sources
Table 3 U.S. in vitro fertilization market, instrument, 2021 - 2033 (USD Million)
Table 4 U.S. in vitro fertilization market, procedure type, 2021 - 2033 (USD Million)
Table 5 U.S. in vitro fertilization market, end - use, 2021 - 2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 U.S. in vitro fertilization market: market outlook
Figure 9 U.S. in vitro fertilization competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 U.S. in vitro fertilization market driver impact
Figure 14 U.S. in vitro fertilization market restraint impact
Figure 15 U.S. in vitro fertilization market: Instrument movement analysis, 2025 & 2033
Figure 16 U.S. in vitro fertilization market: Instrument outlook and key takeaways, 2021 - 2033
Figure 17 Radiofrequency ablation market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 18 Disposable devices market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 19 Culture Media market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 20 Cryopreservation media market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 21 Embryo culture media market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 22 Ovum processing media market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 23 Sperm processing media market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 24 Capital equipment market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 25 Sperm analyzer systems market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 26 Imaging systems market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 27 Ovum aspiration pumps market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 28 Micromanipulator market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 29 Incubators market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 30 Gas analyzers market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 31 Laser systems market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 32 Cryosystems market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 33 Sperm separation devices market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 34 IVF cabinets market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 35 Anti - vibration tables market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 36 Witness systems market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 37 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 38 U.S. in vitro fertilization market: Procedure type movement Analysis, 2025 & 2033
Figure 39 U.S. in vitro fertilization market: Procedure type outlook and key takeaways, 2021 - 2033
Figure 40 Surgical ablation market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 41 Fresh donor market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 42 Frozen donor market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 43 Fresh non - donor market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 44 Frozen non - donor market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 45 U.S. in vitro fertilization market: End-use movement Analysis, 2025 & 2033
Figure 46 U.S. in vitro fertilization market: End-use outlook and key takeaways, 2021 - 2033
Figure 47 Fertility clinics market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 48 Hospitals and other settings market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 49 Company categorization
Figure 50 Company market position analysis, 2025
Figure 51 Strategy mapping

Companies Mentioned

  • Bayer AG
  • Cook Medical LLC
  • EMD Serono, Inc.
  • Ferring B.V.
  • FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
  • Genea Biomedx
  • EMD Serono, Inc. (Merck KGaA)
  • Merck & Co., Inc.
  • The Cooper Companies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Vitrolife
  • Nova IVF
  • RMA Network (Reproductive Medicine Associates)
  • U.S. Fertility